상처 치료 기기 시장 - 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of wound care devices Market

The global wound care devices market is witnessing steady growth, fueled by the rising prevalence of chronic diseases, diabetes, and an aging population worldwide. The market was valued at USD 22.37 billion in 2025, projected to reach USD 23.89 billion in 2026, and is expected to grow to USD 36.16 billion by 2034, registering a CAGR of 5.32% during the forecast period. North America dominated the market in 2025 with a 37.90% share, driven by high demand for wound care devices and well-established reimbursement policies.

Wound care devices are specifically designed to provide effective treatment for chronic and acute wounds, including diabetic ulcers, pressure ulcers, and surgical wounds. According to the National Health Service (NHS), approximately 4.5 million people in the U.K. suffer from diabetes, with 10% experiencing diabetic foot ulcers. Severe grade-IV ulcers result in an estimated 7,000 foot amputations annually in the U.K. alone, highlighting the importance of advanced wound care technologies.

COVID-19 Impact

The COVID-19 pandemic had a temporary negative impact on the market. Wound care services were excluded from essential procedure lists in several countries, and many hospitals shut down their wound care departments to prevent transmission. This led to reduced adoption of devices, disrupted supply chains, and restricted professional assistance for device usage. However, telemedicine and virtual consultations emerged as alternative solutions, supporting limited use in non-emergency cases.

Market Drivers

The primary drivers of market growth include:

• Rising prevalence of diabetes and chronic wounds: Increasing incidence of diabetic foot ulcers and pressure ulcers among the elderly is significantly driving demand.
• Popularity of Negative Pressure Wound Therapy (NPWT): NPWT is highly efficient in managing wound exudates, reducing healing time, and improving patient outcomes. For instance, Smith & Nephew's PICO 14 system provides up to 14 days of single-use NPWT, highlighting innovations in device design.
• Technological advancements and product innovations: Key players focus on developing advanced wound care solutions to meet unmet clinical needs, such as KCI's FDA-approved DERMATAC Drape used with NPWT systems.

Market Restraints

The adoption of wound care devices in emerging countries is restrained by high costs and unfavorable reimbursement policies. For example, in India, NPWT for 15 days costs USD 11.16 per patient, slightly higher than conventional wound dressings at USD 10.41, leading to limited adoption among patients relying on out-of-pocket payments.

Segmentation Analysis

By Product Type

• Negative Pressure Wound Therapy (NPWT) dominated the market with a 44.27% share in 2026, due to its efficiency in wound healing and exudate management.
• Hyperbaric Oxygen Therapy (HBOT) and Extracorporeal Shock Wave Therapy (ESWT) segments are expected to grow at moderate CAGRs during the forecast period.

By Indication

• Diabetic foot ulcers segment leads due to rising global diabetes cases.
• Surgical wounds segment is anticipated to grow significantly due to increasing surgical procedures worldwide.
• Pressure ulcers segment is also expected to see substantial growth, driven by the aging population.

By End User

• Hospitals dominate the market due to higher adoption of devices in large and mid-sized facilities.
• Homecare settings are expected to witness faster growth due to portable devices, rental schemes, and patient-friendly solutions.

Regional Insights

• North America: Market size of USD 8.48 billion in 2025, projected to reach USD 7.89 billion by 2026. Growth is supported by high patient population and reimbursement policies.
• Europe: Significant growth driven by chronic wound prevalence and innovative devices. UK projected at USD 0.85 billion, Germany USD 2.13 billion by 2026.
• Asia Pacific: High CAGR expected due to increasing healthcare awareness and spending. Japan projected at USD 1.29 billion, China USD 2.46 billion, India USD 0.38 billion by 2026.
• Latin America & Middle East & Africa: Moderate growth expected, limited by lower device penetration and preference for low-cost dressings.

Key Industry Players

The market is moderately consolidated, with Smith & Nephew, 3M, and DeRoyal Industries, Inc. accounting for significant market shares. These players focus on innovation, product development, and portfolio expansion. Other key players include Cardinal Health, Talley Group Ltd, ConvaTec Inc., Devon Medical Products, BSN Medical, and Medela AG.

Recent Developments:

• October 2019: 3M acquired Acelity, Inc., strengthening its wound care portfolio.
• October 2018: ConvaTec Inc. received FDA approval for AVELLE, an NPWT system using hydrofibre technology.
• January 2020: Smith & Nephew reported positive clinical trial results for its PICO single-use NPWT system in lower extremity ulcers.

Conclusion

The global wound care devices market is expected to grow from USD 22.37 billion in 2025 to USD 36.16 billion by 2034, at a CAGR of 5.32%. Market expansion is driven by rising diabetes prevalence, growing geriatric populations, increasing surgical procedures, and adoption of NPWT systems. North America continues to lead the market, while Asia Pacific is anticipated to witness the fastest growth due to rising healthcare awareness and infrastructure investments. Technological innovations, product launches, and strategic acquisitions by leading players are set to sustain market growth over the forecast period.

By Product Type

• Negative pressure Wound Therapy (NPWT)
• Hyperbaric Oxygen Therapy (HBOT)
• Extracorporeal Shock Wave Therapy (ESWT)
• Others

By Indication

• Diabetic Ulcers
• Pressure Ulcers
• Surgical wounds
• Others

By End User

• Hospitals
• Clinics
• Homecare settings
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• The Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of key Indications, 2025(Key Countries)
• 4.2. Economic cost Burden, Chronic Wounds (Key Countries)
• 4.3. Reimbursement Scenario, Key Countries
• 4.4. Pricing Analysis, 2021
• 4.5. Impact of Covid-19 on the Wound Care Devices Market

5. Global Wound Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Negative Pressure Wound Therapy
  • 5.2.2. Hyperbaric Oxygen Therapy
  • 5.2.3. Extracorporeal Shock Wave Therapy
  • 5.2.4. Others (Compression Therapy, etc.)
• 5.3. Market Analysis, Insights and Forecast - By Indication
  • 5.3.1. Diabetic Foot Ulcers
  • 5.3.2. Pressure Ulcers
  • 5.3.3. Surgical Wounds
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. Clinics
  • 5.4.3. Home Care Settings
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Wound Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Product
  • 6.2.1. Negative Pressure Wound Therapy
  • 6.2.2. Hyperbaric Oxygen Therapy
  • 6.2.3. Extracorporeal Shock Wave Therapy
  • 6.2.4. Others (Compression Therapy, etc.)
• 6.3. Market Analysis, Insights and Forecast - By Indication
  • 6.3.1. Diabetic Foot Ulcers
  • 6.3.2. Pressure Ulcers
  • 6.3.3. Surgical Wounds
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals
  • 6.4.2. Clinics
  • 6.4.3. Home Care Settings
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Wound Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Product
  • 7.2.1. Negative Pressure Wound Therapy
  • 7.2.2. Hyperbaric Oxygen Therapy
  • 7.2.3. Extracorporeal Shock Wave Therapy
  • 7.2.4. Others (Compression Therapy, etc.)
• 7.3. Market Analysis, Insights and Forecast - By Indication
  • 7.3.1. Diabetic Foot Ulcers
  • 7.3.2. Pressure Ulcers
  • 7.3.3. Surgical Wounds
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals
  • 7.4.2. Clinics
  • 7.4.3. Home Care Settings
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. Germany
  • 7.5.2. U.K.
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Wound Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Product
  • 8.2.1. Negative Pressure Wound Therapy
  • 8.2.2. Hyperbaric Oxygen Therapy
  • 8.2.3. Extracorporeal Shock Wave Therapy
  • 8.2.4. Others (Compression Therapy, etc.)
• 8.3. Market Analysis, Insights and Forecast - By Indication
  • 8.3.1. Diabetic Foot Ulcers
  • 8.3.2. Pressure Ulcers
  • 8.3.3. Surgical Wounds
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals
  • 8.4.2. Clinics
  • 8.4.3. Home Care Settings
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.5.1. China
  • 8.5.2. India
  • 8.5.3. Japan
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Wound Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Product
  • 9.2.1. Negative Pressure Wound Therapy
  • 9.2.2. Hyperbaric Oxygen Therapy
  • 9.2.3. Extracorporeal Shock Wave Therapy
  • 9.2.4. Others (Compression Therapy, etc.)
• 9.3. Market Analysis, Insights and Forecast - By Indication
  • 9.3.1. Diabetic Foot Ulcers
  • 9.3.2. Pressure Ulcers
  • 9.3.3. Surgical Wounds
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals
  • 9.4.2. Clinics
  • 9.4.3. Home Care Settings
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Wound Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Product
  • 10.2.1. Negative Pressure Wound Therapy
  • 10.2.2. Hyperbaric Oxygen Therapy
  • 10.2.3. Extracorporeal Shock Wave Therapy
  • 10.2.4. Others (Compression Therapy, etc.)
• 10.3. Market Analysis, Insights and Forecast - By Indication
  • 10.3.1. Diabetic Foot Ulcers
  • 10.3.2. Pressure Ulcers
  • 10.3.3. Surgical Wounds
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals
  • 10.4.2. Clinics
  • 10.4.3. Home Care Settings
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.5.1. South Africa
  • 10.5.2. GCC
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2021)
• 11.3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 11.3.1. Smith & Nephew
    • 11.3.1.1. Overview,
    • 11.3.1.2. Products,
    • 11.3.1.3. SWOT Analysis,
    • 11.3.1.4. Recent Developments,
    • 11.3.1.5. Strategies,
    • 11.3.1.6. Financials (Based on Availability)
  • 11.3.2. Talley Group Ltd
    • 11.3.2.1. Overview,
    • 11.3.2.2. Products,
    • 11.3.2.3. SWOT Analysis,
    • 11.3.2.4. Recent Developments,
    • 11.3.2.5. Strategies,
    • 11.3.2.6. Financials (Based on Availability)
  • 11.3.3. Cardinal Health
    • 11.3.3.1. Overview,
    • 11.3.3.2. Products,
    • 11.3.3.3. SWOT Analysis,
    • 11.3.3.4. Recent Developments,
    • 11.3.3.5. Strategies,
    • 11.3.3.6. Financials (Based on Availability)
  • 11.3.4. ConvaTec Inc.
    • 11.3.4.1. Overview,
    • 11.3.4.2. Products,
    • 11.3.4.3. SWOT Analysis,
    • 11.3.4.4. Recent Developments,
    • 11.3.4.5. Strategies,
    • 11.3.4.6. Financials (Based on Availability)
  • 11.3.5. DeRoyal Industries, Inc.
    • 11.3.5.1. Overview,
    • 11.3.5.2. Products,
    • 11.3.5.3. SWOT Analysis,
    • 11.3.5.4. Recent Developments,
    • 11.3.5.5. Strategies,
    • 11.3.5.6. Financials (Based on Availability)
  • 11.3.6. Devon Medical Products
    • 11.3.6.1. Overview,
    • 11.3.6.2. Products,
    • 11.3.6.3. SWOT Analysis,
    • 11.3.6.4. Recent Developments,
    • 11.3.6.5. Strategies,
    • 11.3.6.6. Financials (Based on Availability)
  • 11.3.7. BSN Medical
    • 11.3.7.1. Overview,
    • 11.3.7.2. Products,
    • 11.3.7.3. SWOT Analysis,
    • 11.3.7.4. Recent Developments,
    • 11.3.7.5. Strategies,
    • 11.3.7.6. Financials (Based on Availability)
  • 11.3.8. Medela AG
    • 11.3.8.1. Overview,
    • 11.3.8.2. Products,
    • 11.3.8.3. SWOT Analysis,
    • 11.3.8.4. Recent Developments,
    • 11.3.8.5. Strategies,
    • 11.3.8.6. Financials (Based on Availability)

12. Strategic Recommendations